111 Results

People

  1. Giralt
    Giralt
  2. Hassoun
    Hassoun
  3. Landgren
    Landgren
  4. Dhodapkar
    Dhodapkar
  5. Comenzo
    Comenzo
  6. Landau
    Landau
  7. Lesokhin
    Lesokhin
  8. Mailankody
    Mailankody
  9. Shah
    Shah
  10. Devlin
    Devlin

Groups

  1. Department of Medicine (63)
  2. Hematologic Malignancies, Division of (54)
  3. Center for Hematologic Malignancies (51)
  4. Bone Marrow Transplant (25)
  5. Myeloma (23)
  6. Survivorship Research (20)
  7. Hematologic Malignancies Research (16)
  8. Department of Pathology and Laboratory Medicine (8)
  9. GSK Faculty (8)
  10. Solid Tumor Oncology Division (8)
  1. "myeloma"
Formats
  1. Journal Article (93)
  2. Review (5)
  3. Book Section (4)
  4. Meeting Abstract (3)
  5. Research Letter (3)
  6. Conference Paper (1)
  7. Correspondence (1)
  8. Editorial (1)
Groups
  1. Department of Medicine (63)
  2. Hematologic Malignancies, Division of (54)
  3. Center for Hematologic Malignancies (51)
  4. Bone Marrow Transplant (25)
  5. Myeloma (23)
  6. Survivorship Research (20)

More Groups

People
  1. Sergio Giralt (16)
  2. Carl Landgren (9)
  3. Hani Hassoun (9)
  4. Madhav Dhodapkar (8)
  5. Heather Landau (7)
  6. Raymond Comenzo (7)

More People

Years
  1. 2025 (8)
  2. 2024 (6)
  3. 2023 (5)
  4. 2022 (1)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (7)
  2. Blood (6)
  3. British Journal of Haematology (6)
  4. Leukemia and Lymphoma (6)
  5. Cancer (5)
  6. Clinical Lymphoma, Myeloma and Leukemia (4)

More Publications

Publishers
  1. Elsevier Inc. (24)
  2. John Wiley & Sons (10)
  3. Nature Publishing Group (9)
  4. American Society of Hematology (8)
  5. Wiley Blackwell (8)
  6. Taylor & Francis Group (6)

More Publishers

Results (111)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunotyping provides equivalent results to immunofixation in a population with a high prevalence of monoclonal gammopathies
    Journal Article

    Thoren, K. L.; McCash, S. I.; Murata, K.
    Journal of Applied Laboratory Medicine (2021)

    Fulltext@MSK | Save
  • Melflufen plus dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) exposed or refractory to prior alkylators: A pooled analysis of the O-12-M1 and HORIZON studies
    Meeting Abstract

    Rodriguez-Otero, P.; Mateos, M. V.; Oriol, A.; Larocca, A.; Blade, J.; Cavo, M.; Leleu, X.; Nadeem, O.; Hiemenz, J. W.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • HORIZON (OP-106): Melflufen plus dexamethasone in 55 patients with relapsed/refractory multiple myeloma (RRMM) with extramedullary disease (EMD): Subgroup analysis
    Meeting Abstract

    Richardson, P. G.; Mateos, M. V.; Oriol, A.; Larocca, A.; Cavo, M.; Rodríguez-Otero, P.; Leleu, X.; Norkin, M.; Nadeem, O.; Hiemenz, J. W.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States
    Journal Article

    Badar, T.; Hari, P.; Dávila, O.; Fraser, R.; Wirk, B.; Dhakal, B.; Freytes, C. O.; Rodriguez Valdes, C.; Lee, C.; Vesole, D. H.; more...
    Cancer (2021)

    Fulltext@MSK | Save
  • Involved free light chains <10 mg/L with treatment predict better outcomes in systemic light-chain amyloidosis
    Research Letter

    Godara, A.; Toskic, D.; Albanese, J.; Rosenthal, B.; Siddiqui, N. S.; Kugelmass, A.; Zhou, P.; Fogaren, T.; Varga, C.; Landau, H. J.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • Outcomes of patients with hematologic malignancies and COVID-19: A report from the ASH Research Collaborative Data Hub
    Journal Article

    Wood, W. A.; Neuberg, D. S.; Colton Thompson, J.; Tallman, M. S.; Sekeres, M. A.; Sehn, L. H.; Anderson, K. C.; Goldberg, A. D.; Pennell, N. A.; Niemeyer, C. M.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma
    Journal Article

    Munshi, P. N.; Vesole, D.; Jurczyszyn, A.; Zaucha, J. M.; St. Martin, A.; Davila, O.; Agrawal, V.; Badawy, S. M.; Battiwalla, M.; Chhabra, S.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • HORIZON (OP-106): Melflufen plus dexamethasone in relapsed/refractory multiple myeloma (RRMM) refractory to pomalidomide and/or an anti-CD38 monoclonal antibody (mAb) - Final primary analysis
    Meeting Abstract

    Richardson, P. G.; Oriol, A.; Larocca, A.; Bladé, J.; Cavo, M.; Rodriguez-Otero, P.; Leleu, X.; Norkin, M.; Nadeem, O.; Hiemenz, J. W.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Measurable disease evaluation in patients with myeloma
    Review

    Roshal, M.
    Best Practice and Research: Clinical Haematology (2020)

    Fulltext@MSK | Save
  • MRI and PET/MRI in hematologic malignancies
    Review

    Mayerhoefer, M. E.; Archibald, S. J.; Messiou, C.; Staudenherz, A.; Berzaczy, D.; Schöder, H.
    Journal of Magnetic Resonance Imaging (2020)

    Fulltext@MSK | Save